| |
| |
|
| Insider
Information: |
Lian Brian |
| Relationship: |
President & CEO, Direc... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,266,453 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$181,112,259 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,266,453 |
|
|
| Total
Value |
$181,112,259 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viking Therapeutics, Inc. |
VKTX |
President & CEO, Direc... |
2024-03-27 |
2,266,453 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-03-27 |
4 |
D |
$83.34 |
$12,830,026 |
D/D |
(153,948) |
2,266,453 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
221,667 |
2,420,401 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-03-01 |
4 |
D |
$85.22 |
$13,875,094 |
D/D |
(162,815) |
2,198,734 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
221,667 |
2,361,549 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-02-09 |
4 |
AS |
$29.90 |
$1,345,500 |
D/D |
(45,000) |
2,139,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-02-08 |
4 |
OE |
$1.23 |
$711,367 |
D/D |
189,079 |
2,404,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-02-08 |
4 |
AS |
$25.75 |
$7,230,784 |
D/D |
(269,079) |
2,184,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-31 |
4 |
AS |
$24.45 |
$2,100,750 |
D/D |
(85,000) |
2,264,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-31 |
4 |
OE |
$1.23 |
$104,550 |
D/D |
85,000 |
2,349,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-30 |
4 |
AS |
$23.95 |
$838,250 |
D/D |
(35,000) |
2,264,882 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-30 |
4 |
OE |
$1.23 |
$43,050 |
D/D |
35,000 |
2,299,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-04 |
4 |
D |
$18.58 |
$734,876 |
D/D |
(39,552) |
2,264,882 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
310,000 |
2,410,549 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2024-01-03 |
4 |
D |
$17.40 |
$3,734,736 |
D/D |
(214,640) |
2,304,434 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-05-01 |
4 |
AS |
$22.45 |
$1,010,250 |
D/D |
(45,000) |
2,197,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-19 |
4 |
AS |
$21.45 |
$750,750 |
D/D |
(35,000) |
2,242,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-17 |
4 |
OE |
$2.15 |
$268,750 |
D/D |
125,000 |
2,432,963 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-17 |
4 |
AS |
$20.45 |
$3,169,766 |
D/D |
(155,000) |
2,277,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-13 |
4 |
AS |
$18.45 |
$1,463,749 |
D/D |
(79,336) |
2,307,963 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-04-13 |
4 |
OE |
$1.88 |
$102,152 |
D/D |
54,336 |
2,387,299 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-04 |
4 |
D |
$8.42 |
$240,972 |
D/D |
(28,619) |
2,272,963 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-03 |
4 |
D |
$8.52 |
$581,507 |
D/D |
(68,252) |
2,301,582 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
266,667 |
2,369,834 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-30 |
4 |
D |
$9.40 |
$621,594 |
D/D |
(66,127) |
2,103,167 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
President & CEO |
• • – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
121,667 |
2,169,294 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
